Sources Sources Sabet, Katayoun
Understanding the Study's Findings The study, published in JAMA Ophthalmology , suggests that individuals taking semaglutide may be at an increased risk of developing nonarteritic anterior ischemic optic neuropathy (NAION)
Certain individuals should not use semaglutide
However, the clinical development program was halted following serious adverse events, including a death that occurred during a clinical trial, although a definitive causal link with CJC-1295 was not established
If they do not resolve within three months, mention them to your healthcare provider
How Treatment Works Timeline & What to Expect Managing Side Effects Maximizing Your Weight Loss Results Results & Long-Term Maintenance Pricing & Flexible Payment Options Frequently Asked Questions Why Choose BioSpa for Weight Management BioSpa is led by board-certified plastic surgeons with over 35 years of combined experience in aesthetic and medical care